However, the evidence for G-CSF stimulation of liver regeneration is insufficient (19), the clinical trial results for G-CSF were controversial in acute-on-chronic liver failure including AH, and G-CSF provided no survival benefit at 90 days in individuals with sAH, indicating that more evidence is required for further clinical investigation of G-CSF (20, 21). Here, CSF3 is linked to chronic liver failure.